NCT00518492

Study Evaluating the Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500

Duration of Immunity in Healthy Adult Volunteers Who Completed Study 6108A1-500

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 73 (actual)
• Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer · Industry
• Sex: All
• Age: 18 Years – 25 Years
• Healthy volunteers: Accepted

Summary

Upon completion of participation in the 6108A1-500 study, subjects will be asked to consent for this duration of immunity study to provide up to two additional blood samples. SBA \& IgG testing will be done on these samples taken at 6 \& 12 months. The sites participating in this duration of immunity study are the same sites participating in the 6108A1-500 study.

Conditions

• Healthy

Interventions

Type	Name	Description
PROCEDURE	Blood Sampling	Blood draws at 6 and 12 months following end of 6108A1-500 trial.

Timeline

• Start date: 2007-08-01
• Primary completion: 2008-04-01
• Completion: 2008-04-01
• First posted: 2007-08-20
• Last updated: 2009-09-16

Locations

3 sites across 1 country: Australia